In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket1

We demonstrate in this study the great degree of specificity in peptides selected by a class II MHC molecule during processing. In this specific case of the diabetogenic I-Ag7 molecule, the P9 pocket of I-Ag7 plays a critical role in determining the final outcome of epitope selection, a conclusion that is important in interpreting the role of this molecule in autoimmunity. Specifically, we examined the display of naturally processed peptides from APCs expressing either I-Ag7 molecules or a mutant I-Ag7 molecule in which the β57Ser residue was changed to an Asp residue. Using mass spectrometry analysis, we identified over 50 naturally processed peptides selected by I-Ag7-expressing APCs. Many peptides were selected as families with a core sequence and variable flanks. Peptides selected by I-Ag7 were unusually rich in the presence of acidic residues toward their C termini. Many peptides contained short sequences of two to three acidic residues. In binding analysis, we determined the core sequences of many peptides and the interaction of the acidic residues with the P9 pocket. However, different sets of peptides were isolated from APCs bearing a modified I-Ag7 molecule. These peptides did not favor acidic residues toward the carboxyl terminus.

[1]  L Adorini,et al.  The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library. , 2000, International immunology.

[2]  E. Unanue,et al.  Identification of two distinct properties of class II major histocompatibility complex-associated peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[4]  K. Parker,et al.  Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. A. Peterson,et al.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.

[6]  G. Nepom,et al.  Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. , 1996, Journal of immunology.

[7]  Hans-Georg Rammensee,et al.  Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules , 2004, Immunogenetics.

[8]  E. Unanue,et al.  Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Unanue,et al.  Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant. , 1998, Journal of immunology.

[10]  R. Tisch,et al.  Prevention of diabetes in NOD mice by a mutated I-Ab transgene. , 1998, Diabetes.

[11]  M Eisenstein,et al.  Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7. , 1997, International immunology.

[12]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[13]  E. Unanue,et al.  The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. , 1996, Journal of immunology.

[14]  I. Cohen,et al.  Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies. , 1997, Journal of autoimmunity.

[15]  J. Todd,et al.  HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus , 1987, Nature.

[16]  W A Hendrickson,et al.  Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. , 1998, Immunity.

[17]  H. Rammensee,et al.  Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. , 1990, Science.

[18]  C. Janeway,et al.  Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. , 1994, Journal of immunology.

[19]  G. Eisenbarth,et al.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. , 1990, Annual review of immunology.

[20]  E. Unanue,et al.  The role of I-Ag7 beta chain in peptide binding and antigen recognition by T cells. , 1997, International immunology.

[21]  D. Jewell,et al.  Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). , 1997, International immunology.

[22]  H. Mcdevitt,et al.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Kikutani,et al.  The murine autoimmune diabetes model: NOD and related strains. , 1992, Advances in immunology.

[24]  D. Kioussis,et al.  Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus. , 1995, Journal of immunology.

[25]  A. Rudensky,et al.  Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.

[26]  E. Unanue,et al.  Appreciating the Complexity of MHC Class II Peptide Binding: Lysozyme Peptide and I‐Ak , 1996, Immunological reviews.

[27]  I. Cohen,et al.  Induction of diabetes in standard mice by immunization with the p277 peptide of a 60‐kDa heat shock protein , 1995, European journal of immunology.

[28]  E. Unanue,et al.  Isolation and quantitation of a minor determinant of hen egg white lysozyme bound to I-Ak by using peptide-specific immunoaffinity. , 1998, Journal of immunology.

[29]  J. Todd,et al.  Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Dorf,et al.  The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. , 1986, Science.

[31]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[32]  S. Matsushita,et al.  Differential binding of peptides substituted at a putative C-terminal anchor residue to I-Ag7β56Hisβ57Ser and I-Ag7β56Proβ57Asp , 1998, Immunogenetics.

[33]  H. Mcdevitt,et al.  Identification of immunogenic epitopes of GAD 65 presented by A g7 in non-obese diabetic mice , 1997, Immunogenetics.

[34]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[35]  I. Cohen,et al.  Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Unanue,et al.  The lack of consensus for I-A(g7)-peptide binding motifs: is there a requirement for anchor amino acid side chains? , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Mcdevitt,et al.  The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Unanue,et al.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Don C. Wiley,et al.  Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.

[40]  E. Unanue,et al.  Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. , 2000, Immunity.

[41]  K. Garcia,et al.  A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. , 2000, Science.

[42]  Hiroaki Ito,et al.  Analysis of the Role of  Variation of Major Histocompatibility Complex Class II Expression on Nonobese Diabetic (NOD) Peripheral T Cell Response , 1998, The Journal of experimental medicine.

[43]  Vladimir Brusic,et al.  A Peptide-binding Motif for I-Ag7, the Class II Major Histocompatibility Complex (MHC) Molecule of NOD and Biozzi AB/H Mice , 1997, The Journal of experimental medicine.

[44]  K. Wucherpfennig,et al.  pH-dependent Peptide Binding Properties of the Type I Diabetes–associated I-Ag7 Molecule: Rapid Release of CLIP at an Endosomal pH , 1999, The Journal of experimental medicine.

[45]  I. Cohen,et al.  Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[47]  E. Unanue,et al.  Mechanisms and consequences of peptide selection by the I‐Ak class II molecule , 1999, Immunological reviews.

[48]  Hans-Georg Rammensee,et al.  MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.

[49]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[50]  E. Unanue,et al.  Cutting Edge: Thymic Positive Selection and Peripheral Activation of Islet Antigen-Specific T Cells: Separation of Two Diabetogenic Steps by an I-Ag7 Class II MHC β-Chain Mutant , 1998, The Journal of Immunology.

[51]  J. Todd,et al.  Genetic control of autoimmune diabetes in the NOD mouse. , 1995, Annual review of immunology.

[52]  E. Unanue,et al.  Quantitation of Lysozyme Peptides Bound to Class II MHC Molecules Indicates Very Large Differences in Levels of Presentation1 , 2001, The Journal of Immunology.

[53]  William Arbuthnot Sir Lane,et al.  Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. , 1994, International immunology.

[54]  V. Apostolopoulos,et al.  The I-Ag7 MHC Class II Molecule Linked to Murine Diabetes Is a Promiscuous Peptide Binder1 , 2000, The Journal of Immunology.

[55]  K. Ballingall,et al.  The DY sub-region of the sheep MHC contains an A/B gene pair , 2004, Immunogenetics.

[56]  Hans-Georg Rammensee,et al.  Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells , 1990, Nature.